
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EISA in Tandem with ICD to Form In Situ Nanofiber Vaccine for Enhanced Tumor Radioimmunotherapy
Hongjing Luo, Hongmei Cao, Haixue Jia, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Closed Access | Times Cited: 23
Hongjing Luo, Hongmei Cao, Haixue Jia, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 27
Closed Access | Times Cited: 23
Showing 23 citing articles:
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases
Zhongyan Wang, Hongjing Luo, Heping Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 13
Zhongyan Wang, Hongjing Luo, Heping Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 25
Closed Access | Times Cited: 13
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 10
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 10
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 10
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 10
NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy
Minhui Cui, Dongsheng Tang, Hanchen Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Minhui Cui, Dongsheng Tang, Hanchen Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Promotion of Triple Negative Breast Cancer Immunotherapy by Combining Bioactive Radicals with Immune Checkpoint Blockade
Meixu Chen, Linlin Song, Ruhong Zhou, et al.
Acta Biomaterialia (2025)
Open Access | Times Cited: 1
Meixu Chen, Linlin Song, Ruhong Zhou, et al.
Acta Biomaterialia (2025)
Open Access | Times Cited: 1
Light‐Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy
Xian An, Zhuang Chen, Yi Luo, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 7
Xian An, Zhuang Chen, Yi Luo, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 7
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Yuqing Pan, Xiangdong Xue, Xing‐Jie Liang
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 6
Yuqing Pan, Xiangdong Xue, Xing‐Jie Liang
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 6
Bioactive peptide relieves glucocorticoid-induced osteoporosis by giant macrocyclic encapsulation
Yuna Shang, Qingrun Zhu, Jiaming Ding, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 75-87
Closed Access | Times Cited: 5
Yuna Shang, Qingrun Zhu, Jiaming Ding, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 75-87
Closed Access | Times Cited: 5
Short Peptides as Powerful Arsenal for Smart Fighting Cancer
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Joanna Bojarska, Wojciech M. Wolf
Cancers (2024) Vol. 16, Iss. 19, pp. 3254-3254
Open Access | Times Cited: 4
Trypsin-instructed bioactive peptide nanodrugs with cascading transformations to improve chemotherapy against colon cancer
Can Wu, Xiao Wei Zhang, Manman Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Can Wu, Xiao Wei Zhang, Manman Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
Nanofibers in Glioma Therapy: Advances, Applications, and Overcoming Challenges
S.-M. Zhou, Mingyu Zhang, Jiayu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4677-4703
Open Access
S.-M. Zhou, Mingyu Zhang, Jiayu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4677-4703
Open Access
An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy
Jin‐Feng Yu, Yu Wen, Ming Li
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Jin‐Feng Yu, Yu Wen, Ming Li
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
A Pyroptosis‐Inducing Arsenic(III) Nanomicelle Platform for Synergistic Cancer Immunotherapy
Xing Wang, Yuqi Tang, Yuanhang Li, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Xing Wang, Yuqi Tang, Yuanhang Li, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 2
Bimetallic Peroxide-Based Nanotherapeutics for Immunometabolic Intervention and Induction of Immunogenic Cell Death to Augment Cancer Immunotherapy
Min Ho Han, Shiying Zhou, Z. Liao, et al.
Biomaterials (2024) Vol. 315, pp. 122934-122934
Closed Access | Times Cited: 2
Min Ho Han, Shiying Zhou, Z. Liao, et al.
Biomaterials (2024) Vol. 315, pp. 122934-122934
Closed Access | Times Cited: 2
Ferroptosis Amplifier Remodels Redox Homeostasis for Enhanced Cancer Chemoimmunotherapy
Jing Zhang, Yuanwei Pan, Lujie Liu, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 6, pp. 2153-2164
Closed Access | Times Cited: 1
Jing Zhang, Yuanwei Pan, Lujie Liu, et al.
ACS Materials Letters (2024) Vol. 6, Iss. 6, pp. 2153-2164
Closed Access | Times Cited: 1
Nanomedicine-mediated immunogenic cell death and its combination with immune checkpoint blockade therapy
Junbin Chen, Yuxi Zhang, Miao Su, et al.
Science China Technological Sciences (2024) Vol. 67, Iss. 8, pp. 2350-2362
Closed Access | Times Cited: 1
Junbin Chen, Yuxi Zhang, Miao Su, et al.
Science China Technological Sciences (2024) Vol. 67, Iss. 8, pp. 2350-2362
Closed Access | Times Cited: 1
Alkaline Phosphatase-Instructed Peptide Assemblies for Imaging and Therapeutic Applications
Chengfan Wu, Pingge Jiang, Wen Su, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5609-5629
Closed Access
Chengfan Wu, Pingge Jiang, Wen Su, et al.
Biomacromolecules (2024) Vol. 25, Iss. 9, pp. 5609-5629
Closed Access
A dual-targeted trinity of antibody-peptide-drug delivery consortium to combat HER2+ tumor
Yuna Shang, Jiayu Wang, Yinyin Feng, et al.
Chemical Communications (2024) Vol. 60, Iss. 93, pp. 13742-13745
Closed Access
Yuna Shang, Jiayu Wang, Yinyin Feng, et al.
Chemical Communications (2024) Vol. 60, Iss. 93, pp. 13742-13745
Closed Access
Biomaterials Enhancing Localized Cancer Therapy Activated Anti-Tumor Immunity: A Review
J. Yao, Zhencun Cui, Feifei Zhang, et al.
Journal of Materials Chemistry B (2024) Vol. 13, Iss. 1, pp. 117-136
Closed Access
J. Yao, Zhencun Cui, Feifei Zhang, et al.
Journal of Materials Chemistry B (2024) Vol. 13, Iss. 1, pp. 117-136
Closed Access
X-ray triggered bimetallic nanoassemblies as radiosensitizers and STING agonists for a CDT/radio-immunotherapy strategy
Ruifang Chen, Jinglang Gong, Ziyi Yu, et al.
Acta Biomaterialia (2024) Vol. 192, pp. 366-376
Closed Access
Ruifang Chen, Jinglang Gong, Ziyi Yu, et al.
Acta Biomaterialia (2024) Vol. 192, pp. 366-376
Closed Access
Overcoming radiation-induced PD-L1 upregulation by novel gadolinium-palladium nanoplatforms for enhanced tumor radio-immunotherapy
Kai Guo, Hui Liu, Mengmeng Zhang, et al.
Chemical Engineering Journal (2024), pp. 158754-158754
Closed Access
Kai Guo, Hui Liu, Mengmeng Zhang, et al.
Chemical Engineering Journal (2024), pp. 158754-158754
Closed Access